A phase I/II study of paclitaxel and doxorubicin in the treatment of advanced breast cancer

Seminars in Oncology

Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 19-23

  Amadori, D ^a   Frassineti, G L ^a   Zoli, W ^a   Tienghi, A ^a   Ravaioli, A ^a   Giunchi, D C ^a   Gentile, A ^a   Salzano, E ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PACLITAXEL;

ADULT; AGED; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; DIARRHEA; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; FATIGUE; FEMALE; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; MYALGIA; NAUSEA; NEUROTOXICITY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; NEUTROPENIA; PACLITAXEL;

EID: 0029921734     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)